Drugstore chain operator CVS Caremark Corporation ( CVS ) on Thursday saw its price target raised by analysts at Goldman Sachs.
The firm maintained its "Buy" rating while lifting its price target to $44. That new target suggests a 9% upside to the stock's Wednesday closing price of $40.46.
Goldman noted that the company's increased credibility had provided new confidence in its future growth prospects.
CVS Caremark shares were mostly flat in premarket trading Thursday.
The Bottom Line
Shares of CVS Caremark ( CVS ) have a 1.61% dividend yield, based on last night's closing stock price of $40.46. The stock has technical support in the $37 price area. The stock is approaching all-time high levels of $43 a share.
CVS Caremark Corporation ( CVS ) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.3 out of 5 stars.
Created by Dividend.com